Total neoadjuvant therapy involving checkpoint inhibitors in locally advanced MSI/dMMR rectal cancer – a case report

This case highlights the importance of molecular testing in rectal cancer, which should be performed in all advanced cases requiring more intensive oncologic therapy than surgery alone. MSI/dMMR status indicates the need for a specific approach that may significantly improve the outcomes of these patients.